RESPIRATORY IMMUNITY AND THE RATIONALE FOR IMMUNOMODULATION IN THE PREVENTION OF RESPIRATORY TRACT INFECTIONS

This educational summit, supported by an independent grant from OM/Vifor Pharma, brought together physicians specialising in pulmonary medicine, otolaryngology, surgery, immunology, and paediatrics. Delegates from the USA, Europe, and Latin America met and discussed the current unmet needs of patients suffering respiratory tract infections (RTIs). The meeting included plenary lectures, workshops, and interactive sessions, allowing delegates and presenters to debate the most pressing local and international issues in the field.

[1]  Yan-ming Lu,et al.  Bacterial Lysate Increases the Percentage of Natural Killer T Cells in Peripheral Blood and Alleviates Asthma in Children , 2015, Pharmacology.

[2]  C. Reis e Sousa,et al.  Defining dendritic cells. , 2015, Current opinion in immunology.

[3]  D. Broide,et al.  Group 2 innate lymphoid cells: new players in human allergic diseases. , 2015, Journal of investigational allergology & clinical immunology.

[4]  C. Pasquali,et al.  Enhanced Mucosal Antibody Production and Protection against Respiratory Infections Following an Orally Administered Bacterial Extract , 2014, Front. Med..

[5]  Jian Li,et al.  Broncho-Vaxom Attenuates Allergic Airway Inflammation by Restoring GSK3β-Related T Regulatory Cell Insufficiency , 2014, PloS one.

[6]  Ling Han,et al.  A Bacterial Extract of OM-85 Broncho-Vaxom Prevents Allergic Rhinitis in Mice , 2014, American journal of rhinology & allergy.

[7]  P. Sly,et al.  Defective respiratory tract immune surveillance in asthma: a primary causal factor in disease onset and progression. , 2014, Chest.

[8]  A. Mantovani,et al.  Selective Activation of Human Dendritic Cells by OM-85 through a NF-kB and MAPK Dependent Pathway , 2013, PloS one.

[9]  B. Corthésy,et al.  Multi-Faceted Functions of Secretory IgA at Mucosal Surfaces , 2013, Front. Immunol..

[10]  N. Glaichenhaus,et al.  The oral administration of bacterial extracts prevents asthma via the recruitment of regulatory T cells to the airways , 2011, Journal of Translational Medicine.

[11]  W. Bessler,et al.  The bacterial extract OM-85 BV protects mice against influenza and Salmonella infection. , 2010, International immunopharmacology.

[12]  À. Franch,et al.  [The bowel: a key component of the immune system]. , 2008, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

[13]  M. Cesta.  Normal Structure, Function, and Histology of Mucosa-Associated Lymphoid Tissue , 2006, Toxicologic pathology.

[14]  H. S. Warren,et al.  Toll-like receptors. , 2005, Critical care medicine.

[15]  W. Bessler,et al.  Th1-orientated immunological properties of the bacterial extract OM-85-BV. , 2005, European journal of medical research.

[16]  Shizuo Akira,et al.  Toll-like receptor signalling , 2004, Nature Reviews Immunology.

[17]  P. Holt,et al.  Selective Enhancement of Systemic Th1 Immunity in Immunologically Immature Rats with an Orally Administered Bacterial Extract , 2001, Infection and Immunity.

[18]  M. Roth,et al.  Distinct effects of Broncho-Vaxom (OM-85 BV) on gp130 binding cytokines , 2000, Thorax.

[19]  L. Maggi,et al.  Effect of bacterial antigen lysate on IgG and IgA levels in children with recurrent infections and hypogammaglobulinemia. , 1999, Journal of investigational allergology & clinical immunology.

[20]  E. Papakonstantinou,et al.  Induction of interleukin 6 and interleukin 8 expression by Broncho-Vaxom (OM-85 BV) via C-Fos/serum responsive element. , 1996, Thorax.

[21]  J. Mauël.  Stimulation of immunoprotective mechanisms by OM-85 BV. A review of results from in vivo and in vitro studies. , 1994, Respiration; international review of thoracic diseases.

[22]  M. Hallek,et al.  Local immunity in patients with chronic bronchitis and the effects of a bacterial extract, Broncho-Vaxom, on T lymphocytes, macrophages, gamma-interferon and secretory immunoglobulin A in bronchoalveolar lavage fluid and other variables. , 1990, Respiration; international review of thoracic diseases.

[23]  M. Libin,et al.  Activation of natural killer cells and cytokine production in man by bacterial extracts. , 1989, Immunopharmacology and immunotoxicology.

[24]  A. Bosch,et al.  Compensation of cyclophosphamide immunosuppression by a bacterial immunostimulant (Broncho-Vaxom) in mice. , 1984, Journal of immunopharmacology.

[25]  J. Torroella,et al.  Immunoglobulin production in man stimulated by an orally administered bacterial lysate. , 1980, Respiration; international review of thoracic diseases.